Financial Statements — ECX
Balance Sheet
(in billions USD)| Metric | Q2
2025 | Q2
2024 |
|---|
| Cash & Equivalents | 0.09 | 0.79 |
| Inventory | 0.03 | 0.18 |
| Total Current Assets | 0.39 | 0.41 |
| Property, Plant & Equipment | 0.03 | 0.14 |
| Goodwill | 0.00 | -- |
| Intangible Assets | 0.04 | 0.29 |
| Total Non-current Assets | 0.11 | 1.09 |
| Total Assets | 0.49 | 4.03 |
| Short-term Debt | 0.28 | 1.60 |
| Total Current Liabilities | 0.73 | 0.63 |
| Total Non-current Liabilities | 0.06 | 0.12 |
| Total Liabilities | 0.79 | 0.75 |
| Retained Earnings | (1.19) | (7.24) |
| Total Stockholder Equity | (0.29) | (1.44) |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 |
|---|
| Total Revenue | 323.28 | 2,195.32 |
| Cost of Revenue | 273.28 | 233.87 |
| Gross Profit | 50.00 | 495.78 |
| Research & Development | 68.33 | 573.37 |
| Selling, General & Admin | 47.62 | 408.29 |
| Total Operating Expenses | 115.15 | 135.05 |
| Operating Income | (65.15) | (485.65) |
| Pretax Income | (70.59) | (610.52) |
| Tax Provision | 2.05 | (0.03) |
| Net Income | (69.06) | (78.51) |
| Basic EPS | (0.20) | (1.69) |
| Diluted EPS | (0.20) | (0.23) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 |
|---|
| Operating Cash Flow | (82.01) | (416.81) |
| Capital Expenditures | 4.47 | 56.24 |
| Free Cash Flow* | (86.47) | (473.05) |
| Investing Cash Flow | (0.18) | (19.59) |
| Financing Cash Flow | 130.37 | 103.07 |
* Derived from reported values
